Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
The inactivation approach presented in this technology provides for a safe, non-infectious composition for vaccination against the corresponding agent. More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
For research and drug development for treatment of respiratory syncytial virus More
Vaccine strategy relates to the engineering and creation of live-attenuated RSV vaccine candidates by shifting the position of one or more viral genes relative to the viral promoter More
A human monoclonal antibody fragment (Fab) discovered utilizing phage display technology More
Novel, non-invasive vaccine strategy to elicit both systemic and mucosal immunity in typically poorly inductive sites More
Chimeric human-bovine RSVs recombinantly engineered to incorporate nucleotide sequences from both human and bovine RSV strains and produce infectious, chimeric viruses that elicit anti-RSV immunological responses in humans and non-human primates. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 160 pages - $1,495
Jan 2011 - 33 pages - $500
Dec 2010 - 48 pages - $1,000
Jul 2011 - 82 pages - $500
Apr 2010 - 139 pages - $3,800
Apr 2011 - 24 pages - $1,000
Mar 2008 - 123 pages - $3,800
Feb 2011 - 26 pages - $5,700
Nov 2011 - 168 pages - $3,835
Feb 2010 - 220 pages - $4,200
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us